Release 4B Snapshot #1

This page is part of the FHIR Specification (v4.3.0-snapshot1: Release 4B Snapshot #1). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B

Regulatedauthorization-example-basic-drug-auth.xml

Biomedical Research and Regulation Work GroupMaturity Level: N/AStandards Status: InformativeCompartments: Not linked to any defined compartments

Raw XML (canonical form + also see XML Format Specification)

Jump past Narrative

Basic Example of a drug authorization for Equilidem (id = "basic-drug-auth")

<?xml version="1.0" encoding="UTF-8"?>

<RegulatedAuthorization xmlns="http://hl7.org/fhir">
  <id value="basic-drug-auth"/> 
  <text> <status value="generated"/> <div xmlns="http://www.w3.org/1999/xhtml"><p> <b> Generated Narrative</b> </p> <div> <p> Resource &quot;basic-drug-auth&quot; </p> </div> <p> <b> subject</b> : <a> MedicinalProductDefinition/equilidem</a> </p> <p> <b> type</b> : Regulatory Drug Marketing Approval <span>  ()</span> </p> <p> <b> status</b> : active <span>  ([not stated]#active)</span> </p> <p> <b> statusDate</b> : 2016-01-01</p> <p> <b> holder</b> : <a> Organization/EqlidrugCo: EquiliDrugCo Holdings Inc.</a> </p> <p> <b> regulator</b> : <a> Organization/FDA: FDA</a> </p> </div> </text> <subject> 
    <reference value="MedicinalProductDefinition/equilidem"/> 
  </subject> 
  <type> 
    <text value="Regulatory Drug Marketing Approval"/> 
  </type> 
  <status> 
    <coding> 
      <code value="active"/> 
    </coding> 
  </status> 
  <statusDate value="2016-01-01"/> 
  <holder> 
    <reference value="Organization/EqlidrugCo"/> 
    <display value="EquiliDrugCo Holdings Inc."/> 
  </holder> 
  <regulator> 
    <reference value="Organization/FDA"/> 
    <display value="FDA"/> 
  </regulator> 
</RegulatedAuthorization>

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.